Improved high-throughput virus neutralisation assay for antibody estimation against pandemic and seasonal influenza strains from 2009 to 2011

Journal of Virological Methods

Volumn 189, Issue 2, 2013, Pages 341-347

  Terletskaia Ladwig, Elena ^a   Meier, Silvia ^a   Enders, Martin ^a  

^a Gisela Enders and Kollegen MVZ GbR and Institute of Virology Infectious Diseases and Epidemiology   (Germany)

Author keywords

Automated neutralisation assay; Imaging analysis; Influenza

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ADULT; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOMATABLE FOCUS REDUCTION NEUTRALISATION TEST; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEASONAL INFLUENZA; SENSITIVITY ANALYSIS; TREND STUDY; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TITRATION;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; AUTOMATION, LABORATORY; CHILD; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS;

EID: 84876700931     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.03.001     Document Type: Article

References (28)

1. Ananthanarayan C., Paniker K.J. Non-specific inhibitors of influenza viruses in normal sera. Bull. World Health Organ. 1960, 22:409-419.
2. Benne C.A., Harmsen M., De Jong J.C., Kraaijeveld C.A. Neutralization enzyme immunoassay for influenza virus. J. Clin. Microbiol. 1994, 32:987-990.
3. Boliar S., Stanislawek W., Chambers T.M. Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus. J. Vet. Diagn. Invest. 2006, 18:264-267.
4. Chen M.I., Barr I.G., Koh G.C., Lee V.J., Lee C.P., Shaw R., Lin C., Yap J., Cook A.R., Tan B.H., Loh J.P., Barkham T., Chow V.T., Lin R.T., Leo Y.S. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS ONE 2010, 5:e12474.
5. Cohen B.J., Audet S., Andrews N., Beeler J. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 2007, 26:59-66.
6. Coudeville L., Bailleux F., Riche B., Megas F., Andre P., Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model. BMC Med. Res. Methodol. 2010, 10:18.
7. De Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Dev. Biol. (Basel) 2003, 115:63-73.
8. ECDC (European Centre for Disease Prevention and Control), 2012. Influenza virus characterisation - Summary Europe, June 2012. http://ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx%3FID=931.
9. Eichelberger M., Golding H., Hess M., Weir J., Subbarao K., Luke C.J., Friede M., Wood D. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008, 26:4299-4303.
10. Gross P.A., Davis A.E. Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody. J. Clin. Microbiol. 1979, 10:382-384.
11. Grund S., Adams O., Wählisch S., Schweiger B. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J. Virol. Methods 2011, 171:369-373.
12. Harmon M.W., Rota P.A., Walls H.H., Kendal A.P. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J. Clin. Microbiol. 1988, 26:333-337.
13. Klenk H.D., Rott R., Orlich M., Blödorn J. Activation of influenza A viruses by trypsin treatment. Virology 1975, 68:426-439.
14. Lehtoranta L., Villberg A., Santanen R., Ziegler T. A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses. J. Virol. Methods 2009, 159:271-276.
15. Lerdsamran H., Pittayawonganon C., Pooruk P., Mungaomklang A., Iamsirithaworn S., Thongcharoen P., Kositanont U., Auewarakul P., Chokephaibulkit K., Oota S., Pongkankham W., Silaporn P., Komolsiri S., Noisumdaeng P., Chotpitayasunondh T., Sangsajja C., Wiriyarat W., Louisirirotchanakul S., Puthavathana P. Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population. PLoS ONE 2011, 6:e16164.
16. Okuno Y., Tanaka K., Baba K., Maeda A., Kunita N., Ueda S. Rapid focus reduction neutralization test of influenza A and B viruses in microtitre system. J. Clin. Microbiol. 1990, 28:1308-1313.
17. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
18. Sirskyj D., Weltzin R., Golshani A., Anderson D., Bozic J., Diaz-Mitoma F., Azizi A. Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin-streptavidin conjugated antibodies. J. Virol. Methods 2010, 163:459-464.
19. Suzuki T., Tsukimoto M., Kobayashi M., Yamada A., Kawaoka Y., Webster R.G., Suzuki Y. Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera. J. Gen. Virol. 1994, 75:1769-1774.
20. Terletskaia-Ladwig E.N., Enders G., Meier S., Dietz K., Enders M. Development and evaluation of an automatable focus-reduction neutralisation test for detection of measles virus antibodies using imaging analysis. J. Virol. Methods. 2011, 178:124-128.
21. Tyrrell D.A., Horsfall F.L. A procedure which eliminates nonspecific inhibitor from human serum but does not affect specific antibodies against influenza viruses. Immunology 1952, 69:563-574.
22. WHO, 1997. Manual for the Virological Investigation of Polio. World Health Organization, Geneva (WHO/EPI/GEN/97.01).
23. WHO, 2002. Manual on Animal Influenza Diagnosis and Surveillance. World Health Organization, Geneva (WHO/CDS/CSR/NCS/2002.5).
24. WHO, 2009. WHO Biosafety Risk Assessment and Guidelines for the Production and Quality Control of Human Influenza Pandemic Vaccines. World Health Organization, Geneva.
25. WHO, 2011. Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza. World Health Organization, Geneva.
26. WHO, 2011. Standardization of terminology of the pandemic A(H1N1)2009 virus, 18 October, http://www.who.int/influenza/gisrs_laboratory/terminology_ah1n1pdm09/en/index.html.
27. Wood J.M., Major D., Heath A., Newman R.W., Höschler K., Stephenson I., Clark T., Katz J.M., Zambon M.C. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012, 30:210-217.
28. Zakay-Rones Z., Margalith E., Levy R., Katz E. A sensitive plaque inhibition technique for assay of antibodies to influenza virus: use to detect previous antigenic priming with influenza viruses. J. Virol. Methods 1980, 1:355-360.